• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟西汀治疗合并重度抑郁症和酒精使用障碍的青少年:一项3年随访研究。

Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.

作者信息

Cornelius Jack R, Clark Duncan B, Bukstein Oscar G, Kelly Thomas M, Salloum Ihsan M, Wood D Scott

机构信息

Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, 3811 O'Hara Street, PAARC Suite, Pittsburgh, PA 15213, USA.

出版信息

Addict Behav. 2005 May;30(4):807-14. doi: 10.1016/j.addbeh.2004.08.025.

DOI:10.1016/j.addbeh.2004.08.025
PMID:15833583
Abstract

The goal of this 3-year follow-up evaluation was to determine whether the decreases in drinking and in depressive symptoms that were noted during our acute phase study with fluoxetine in comorbid adolescents persisted at a 3-year follow-up evaluation. At the 3-year follow-up evaluation, the group continued to demonstrate significantly fewer DSM criteria for an AUD and fewer BDI depressive symptoms and also consumed fewer standard drinks than they had demonstrated at the baseline of the acute phase study. However, 7 of the 10 participants demonstrated MDD at the 3-year follow-up assessment, and 4 demonstrated an AUD. The presence of a MDD was significantly correlated with the presence of an AUD at both the 1-year and the 3-year follow-up assessments. Four of the participants restarted SSRI medications during the follow-up period. Half of the subjects graduated from college during the 3-year assessment period, despite their residual depressive symptoms and drinking. We conclude that the long-term therapeutic effects of an acute phase trial of fluoxetine plus psychotherapy slowly decrease but did not disappear when fluoxetine is discontinued shortly after the acute phase trial. The high rate of MDD at follow-up suggests that longer term antidepressant medication treatment may be needed for at least some comorbid adolescents.

摘要

这项为期3年的随访评估的目的是确定,在我们对合并患有精神疾病的青少年使用氟西汀进行急性期研究期间所观察到的饮酒量及抑郁症状的减少,在3年随访评估时是否依然存在。在3年随访评估时,该组在酒精使用障碍(AUD)方面符合《精神疾病诊断与统计手册》(DSM)标准的情况及贝克抑郁量表(BDI)所显示的抑郁症状仍显著少于之前,并且其饮用的标准饮品数量也比急性期研究基线时有所减少。然而,10名参与者中有7名在3年随访评估时被诊断为重度抑郁障碍(MDD),4名被诊断为酒精使用障碍。在1年和3年随访评估中,重度抑郁障碍的存在与酒精使用障碍的存在均显著相关。4名参与者在随访期间重新开始服用选择性5-羟色胺再摄取抑制剂(SSRI)类药物。尽管存在残留的抑郁症状和饮酒问题,但在3年评估期内,有一半的受试者大学毕业。我们得出结论,氟西汀联合心理治疗的急性期试验的长期治疗效果会缓慢降低,但在急性期试验后不久停用氟西汀时,这种效果并未消失。随访时重度抑郁障碍的高发生率表明,至少对一些合并患有精神疾病的青少年而言,可能需要更长时间的抗抑郁药物治疗。

相似文献

1
Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.氟西汀治疗合并重度抑郁症和酒精使用障碍的青少年:一项3年随访研究。
Addict Behav. 2005 May;30(4):807-14. doi: 10.1016/j.addbeh.2004.08.025.
2
Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.氟西汀治疗患有酒精使用障碍的抑郁青少年:1年随访评估
J Child Adolesc Psychopharmacol. 2004 Spring;14(1):33-8. doi: 10.1089/104454604773840463.
3
Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.氟西汀治疗伴有酒精使用障碍的青少年共病重性抑郁的双盲安慰剂对照试验。
Addict Behav. 2009 Oct;34(10):905-9. doi: 10.1016/j.addbeh.2009.03.008. Epub 2009 Mar 12.
4
Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.评估认知行为疗法/动机增强疗法(CBT/MET)在共病 MDD/AUD 青少年治疗试验中的效果。
Addict Behav. 2011 Aug;36(8):843-8. doi: 10.1016/j.addbeh.2011.03.016. Epub 2011 Apr 9.
5
Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
Addict Behav. 2001 Sep-Oct;26(5):735-9. doi: 10.1016/s0306-4603(00)00152-0.
6
Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.
Addict Behav. 2005 Oct;30(9):1824-33. doi: 10.1016/j.addbeh.2005.07.007. Epub 2005 Aug 15.
7
A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.一项针对使用选择性5-羟色胺再摄取抑制剂治疗的青少年重度抑郁症患者进行认知行为疗法的随机对照试验。ADAPT试验。
Health Technol Assess. 2008 May;12(14):iii-iv, ix-60. doi: 10.3310/hta12140.
8
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.在青少年抑郁症认知行为疗法(YoDA-C)中添加氟西汀:一项随机、双盲、安慰剂对照、多中心临床试验。
Lancet Psychiatry. 2019 Sep;6(9):735-744. doi: 10.1016/S2215-0366(19)30215-9. Epub 2019 Jul 29.
9
Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.一项随机对照试验,旨在确定在基层医疗中,选择性5-羟色胺再摄取抑制剂加支持性护理与单纯支持性护理相比,对伴有躯体症状的轻至中度抑郁症的临床疗效和成本效益:THREAD(抗抑郁反应阈值)研究。
Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220.
10
TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.共病重度抑郁症和大麻使用障碍的青少年的治疗试验及长期随访评估
Int J Med Biol Front. 2012;18(6):399-411.

引用本文的文献

1
[Not Available].[无可用内容]
CMAJ. 2024 May 20;196(19):E685-E686. doi: 10.1503/cmaj.149917-l-f.
2
Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.关于加拿大高危饮酒和酒精使用障碍临床管理指南中反对开具选择性5-羟色胺再摄取抑制剂的建议的相关担忧。
CMAJ. 2024 Mar 17;196(10):E346-E347. doi: 10.1503/cmaj.149917-l.
3
Course of late-life depression with alcoholism following combination therapy.
联合治疗后伴有酒精中毒的老年抑郁症病程
J Stud Alcohol Drugs. 2009 Mar;70(2):237-41. doi: 10.15288/jsad.2009.70.237.
4
Interventions for alcohol use and alcohol use disorders in youth.青少年饮酒及酒精使用障碍的干预措施。
Alcohol Res Health. 2004;28(3):163-74.
5
A developmental perspective on alcohol and youths 16 to 20 years of age.关于16至20岁青少年饮酒问题的发展视角。
Pediatrics. 2008 Apr;121 Suppl 4(Suppl 4):S290-310. doi: 10.1542/peds.2007-2243D.
6
Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence.大麻戒断在寻求治疗的大麻依赖和重度抑郁青少年中很常见,且与迅速复吸成瘾有关。
Addict Behav. 2008 Nov;33(11):1500-1505. doi: 10.1016/j.addbeh.2008.02.001. Epub 2008 Feb 11.